Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON (JNJ)

289
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

08/21/2012 | 06:13pm US/Eastern
   By Ben Fox Rubin 
 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

React to this article
Latest news on JOHNSON & JOHNSON
04:08a RECKITT BENCKISER : Press release: CMA sets out provisional concerns over lubric..
02:52aDJRECKITT BENCKISER : Personal Lubricants Buy May Lessen Competition -UK Regulator
05/21 JOHNSON & JOHNSON : Risperdal Lawyers at Bernstein Liebhard LLP Look Ahead to Ju..
05/21 JOHNSON & JOHNSON : Talcum Powder Lawsuit News from Attorneys Handling Missouri ..
05/21 JOHNSON & JOHNSON : Reports Commitment of $25 Million to Operation Smile Over Ne..
05/21 JOHNSON & JOHNSON : Talcum Powder Lawsuit News from Attorneys Handling Missouri ..
05/21 JOHNSON & JOHNSON : ex-dividend day
05/20 JOHNSON & JOHNSON : expects lucrative return on drug pipeline with slew of produ..
05/20 JOHNSON & JOHNSON : Rosalynn Carter Institute for Caregiving Supports Effort to ..
05/20 JOHNSON & JOHNSON : Achillion sinks after partnering with Johnson & Johnson
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF